Israel
· Delayed Price · Currency is ILS · Price in ILAPlantArc Bio Statistics
Total Valuation
PlantArc Bio has a market cap or net worth of ILS 5.73 million. The enterprise value is -4.68 million.
| Market Cap | 5.73M |
| Enterprise Value | -4.68M |
Important Dates
The next estimated earnings date is Thursday, November 28, 2024.
| Earnings Date | Nov 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PlantArc Bio has 3.32 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.32M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 44.68% |
| Owned by Institutions (%) | 4.13% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| PB Ratio | 0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.86 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 5.53 |
Financial Position
The company has a current ratio of 9.59, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.59 |
| Quick Ratio | 9.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -267.09 |
Financial Efficiency
Return on equity (ROE) is -21.64% and return on invested capital (ROIC) is -15.64%.
| Return on Equity (ROE) | -21.64% |
| Return on Assets (ROA) | -14.38% |
| Return on Capital (ROIC) | -15.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.50% in the last 52 weeks. The beta is -0.16, so PlantArc Bio's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -54.50% |
| 50-Day Moving Average | 201.47 |
| 200-Day Moving Average | 293.97 |
| Relative Strength Index (RSI) | 33.32 |
| Average Volume (20 Days) | 15,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PlantArc Bio had revenue of ILS 4.74 million and -2.52 million in losses. Loss per share was -0.76.
| Revenue | 4.74M |
| Gross Profit | 2.33M |
| Operating Income | -2.94M |
| Pretax Income | -2.52M |
| Net Income | -2.52M |
| EBITDA | -2.83M |
| EBIT | -2.94M |
| Loss Per Share | -0.76 |
Balance Sheet
The company has 10.53 million in cash and 116,000 in debt, giving a net cash position of 10.41 million or 3.14 per share.
| Cash & Cash Equivalents | 10.53M |
| Total Debt | 116,000 |
| Net Cash | 10.41M |
| Net Cash Per Share | 3.14 |
| Equity (Book Value) | 10.52M |
| Book Value Per Share | 3.17 |
| Working Capital | 10.07M |
Cash Flow
In the last 12 months, operating cash flow was -794,000 and capital expenditures -51,000, giving a free cash flow of -845,000.
| Operating Cash Flow | -794,000 |
| Capital Expenditures | -51,000 |
| Free Cash Flow | -845,000 |
| FCF Per Share | -0.25 |
Margins
Gross margin is 49.10%, with operating and profit margins of -62.02% and -53.16%.
| Gross Margin | 49.10% |
| Operating Margin | -62.02% |
| Pretax Margin | -53.16% |
| Profit Margin | -53.16% |
| EBITDA Margin | -59.76% |
| EBIT Margin | -62.02% |
| FCF Margin | -17.84% |
Dividends & Yields
PlantArc Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PlantArc Bio has an Altman Z-Score of 3.34.
| Altman Z-Score | 3.34 |
| Piotroski F-Score | n/a |